In 2016, a consortium of academic laboratories from Europe, Australia, and North America reported a collection of 537 serially transplantable PDXs, representing all 3 clinical subtypes of breast cancer: estrogen receptor positive (ER+), HER2+, and triple-negative breast cancer (TNBC) [16]. This evidence concerns the gene ESR1 and breast cancer.